摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-羟基天冬氨酸 | 71653-06-0

中文名称
3-羟基天冬氨酸
中文别名
——
英文名称
3-hydroxyaspartic acid
英文别名
β-hydroxyaspartic acid;2-amino-3-hydroxybutanedioic acid
3-羟基天冬氨酸化学式
CAS
71653-06-0
化学式
C4H7NO5
mdl
——
分子量
149.103
InChiKey
YYLQUHNPNCGKJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    287-288℃ (decomposition)
  • 沸点:
    368.7±42.0 °C(Predicted)
  • 密度:
    1.738±0.06 g/cm3(Predicted)
  • 稳定性/保质期:

    正常条件下稳定,远离氧化物。

计算性质

  • 辛醇/水分配系数(LogP):
    -4.4
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    121
  • 氢给体数:
    4
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2922509090
  • 储存条件:
    存放在密封容器内,并置于阴凉、干燥处。请将存储地点远离氧化剂,并避免火源及强光照射。

SDS

SDS:cd92cd217013812314ee023e0bcd53dc
查看
3-Hydroxyaspartic Acid
SAFETY DATA SHEET

Section 1. IDENTIFICATION
Product name: 3-Hydroxyaspartic Acid

Section 2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS Not classified
Not classified
HEALTH HAZARDS
ENVIRONMENTAL HAZARDS Not classified
GHS label elements, including precautionary statements
Pictograms or hazard symbols None
No signal word
Signal word
Hazard statements None
None
Precautionary statements:

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Components: 3-Hydroxyaspartic Acid
Percent: >98.0%(T)(N)
CAS Number: 71653-06-0
Synonyms: 2-Amino-3-hydroxysuccinic Acid
Chemical Formula: C4H7NO5

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Rinse skin with
water/shower. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
Protection of first-aiders: A rescuer should wear personal protective equipment, such as rubber gloves and air-
tight goggles.

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Specific hazards arising Take care as it may decompose upon combustion or in high temperatures to
from the chemical: generate poisonous fume.
3-Hydroxyaspartic Acid

Section 5. FIRE-FIGHTING MEASURES
Precautions for firefighters: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

Section 6. ACCIDENTAL RELEASE MEASURES
Use personal protective equipment. Keep people away from and upwind of spill/leak.
Personal precautions,
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Handling is performed in a well ventilated place. Wear suitable protective equipment.
Technical measures:
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Conditions for safe storage, including any
incompatibilities
Storage conditions: Keep container tightly closed. Store in a cool and dark place.
Store under inert gas.
Store away from incompatible materials such as oxidizing agents.
Air-sensitive
Packaging material: Comply with laws.

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Install a closed system or local exhaust as possible so that workers should not be
Engineering controls:
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Hand protection: Protective gloves.
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Form: Crystal- Powder
White - Almost white
Colour:
Odour: No data available
pH: No data available
Melting point/freezing point:No data available
No data available
Boiling point/range:
Flash point: No data available
Flammability or explosive
limits:
No data available
Lower:
Upper: No data available
No data available
Relative density:
Solubility(ies):
No data available
[Water]
[Other solvents] No data available
3-Hydroxyaspartic Acid

Section 10. STABILITY AND REACTIVITY
Chemical stability: Stable under proper conditions.
Possibility of hazardous No special reactivity has been reported.
reactions:
Incompatible materials: Oxidizing agents
Hazardous decomposition Carbon monoxide, Carbon dioxide, Nitrogen oxides (NOx)
products:

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
IARC = No data available
No data available
NTP =
Reproductive toxicity: No data available

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobility in soil
No data available
Log Pow:
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

Section 14. TRANSPORT INFORMATION
Does not correspond to the classification standard of the United Nations
Hazards Class:
UN-No: Not listed

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26, 2002
and revised on February 16,2011): Safe use and production, the storage of a dangerous chemical, transport,
loading and unloading were prescribed.
3-Hydroxyaspartic Acid


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-羟基天冬氨酸 在 D-erythro-3-hydroxyaspartate dehydratase 作用下, 反应 14.0h, 以35.1%的产率得到2-(S)-amino-3-(R)-hydroxysuccinic acid
    参考文献:
    名称:
    作用于假单胞菌属(Pseudomonas sp。)d-赤型-3-羟基天冬氨酸的脱水酶的分离和氨基酸序列。N99及其在光学活性3-羟基天冬氨酸的生产中的应用。
    摘要:
    从土壤分离的细菌假单胞菌(Pseudomonas sp。)的无细胞提取物中纯化出催化氨分解酶反应的酶,该酶用于将d-赤型-3-羟基天冬氨酸转化为草酰乙酸。N99。该酶对1-苏--3-羟基天冬氨酸和d-赤--3-羟基天冬氨酸表现出氨裂合酶活性,但对其他3-羟基天冬氨酸异构体则没有。该酶的推导的氨基酸序列属于丝氨酸/苏氨酸脱水酶家族,显示出与假单胞菌属的1-苏氨酸-3-羟基天冬氨酸氨裂合酶(EC 4.3.1.16)的序列相似。T62(74%)和酿酒酵母(64%)和来自粟酒裂殖酵母的丝氨酸消旋酶(65%)。这些结果表明,该酶类似于假单胞菌属的1-苏--3-羟基天冬氨酸氨裂合酶。T62,它不作用于d-erythro-3-hydroxyaspartate。然后,我们还使用在大肠杆菌中表达的重组酶从相应的dl-外消旋混合物中生成了光学纯的1-赤--3-羟基天冬氨酸和d-苏--3-羟基天冬氨酸。此处报道
    DOI:
    10.1080/09168451.2017.1295804
  • 作为产物:
    描述:
    (2S)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-18-[3-(diaminomethylideneamino)propyl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide 生成 3-羟基天冬氨酸
    参考文献:
    名称:
    TYMIAK, ADRIENNE A.;MCCORMICK, TERRENCE J.;UNGER, STEVE E., J. ORG. CHEM., 54,(1989) N, C. 1149-1157
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Structure-guided engineering of<i>Pseudomonas dacunhae</i><scp>l</scp>-aspartate β-decarboxylase for<scp>l</scp>-homophenylalanine synthesis
    作者:Min Zhang、Pengfei Hu、Yu-Cong Zheng、Bu-Bing Zeng、Qi Chen、Zhi-Jun Zhang、Jian-He Xu
    DOI:10.1039/d0cc05871h
    日期:——
    Structure-guided engineering of Pseudomonas dacunhae L-aspartate β-decarboxylase (AspBDC) resulted in a double mutant (R37A/T382G) with remarkable 15,400-fold improvement in specific activity reaching 216 mU/mg, towards the target substrate 3(R)-benzyl-L-aspartate. A novel strategy for enzymatic synthesis of L-homophenylalanine was developed by using the variant as biocatalyst affording 75% product
    假单胞菌L-天冬氨酸β-脱羧酶(AspBDC)的结构指导工程导致了一个双突变体(R37A / T382G),其比活性朝目标底物3(R)-的比活性显着提高了15,400倍,达到216 mU / mg。 L-天冬氨酸苄酯。通过使用该变体作为生物催化剂,开发了一种酶促合成L-高苯丙氨酸的新策略,可在12小时内提供75%的产物收率。我们的结果强调了工程化的AspBDC在生物催化合成药物Relavent和增值非天然L-氨基酸方面的潜力
  • Fixation of Molecular Nitrogen Using Aliphatic Carboxylic Acid by Nitrogen Arc Plasma. Formation of Amino Acids
    作者:Michiaki Takasaki、Kaoru Harada
    DOI:10.1246/cl.1987.365
    日期:1987.2.5
    When argon-nitrogen plasma was blown into an aqueous solution containing aliphatic carboxylic acids, formation of several amino acids and amines was identified.
    氮等离子体喷入含有脂肪族羧酸溶液中时,发现形成了几种氨基酸和胺。
  • RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF
    申请人:The Johns Hopkins University
    公开号:US20210094933A1
    公开(公告)日:2021-04-01
    The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
    本公开提供了受免疫蛋白配体家族FK506和雷帕霉素天然产物启发的大环化合物。生成包含FK506和雷帕霉素结合结构域的Rapafucin大环化合物库,应具有作为治疗疾病新药的潜力。
  • OXIDATIVE DEGRADATION OF β- AND γ-AMINO ACIDS BY CONTACT GLOW DISCHARGE ELECTROLYSIS
    作者:Kaoru Harada、Jun-ichi Terasawa
    DOI:10.1246/cl.1980.441
    日期:1980.4.5
    The degradation of β- and γ-amino acids in aqueous solutions by contact glow discharge electrolysis(CGDE) was studied. It was found that the reaction is actually a stepwise oxidative degradation by hydroxyl radical produced by CGDE.
    研究了接触辉光放电电解法(CGDE)降解溶液中的β-和γ-氨基酸。研究发现,该反应实际上是由 CGDE 产生的羟基自由基逐步氧化降解的过程。
  • Total Synthesis and Biological Evaluation of Rakicidin A and Discovery of a Simplified Bioactive Analogue
    作者:Michail Tsakos、Lise L. Clement、Eva S. Schaffert、Frank N. Olsen、Sebastiano Rupiani、Rasmus Djurhuus、Wanwan Yu、Kristian M. Jacobsen、Nikolaj L. Villadsen、Thomas B. Poulsen
    DOI:10.1002/anie.201509926
    日期:2016.1.18
    We report a concise asymmetric synthesis of rakicidin A, a macrocyclic depsipeptide that selectively inhibits the growth of hypoxic cancer cells and stem‐like leukemia cells. Key transformations include a diastereoselective organocatalytic cross‐aldol reaction to build the polyketide portion of the molecule, a highly hindered ester fragment coupling reaction, an efficient Helquist‐type Horner—Wadsworth—Emmons
    我们报告了rakicidin A的简明不对称合成,rakicidin A是一种大环二肽,选择性抑制缺氧性癌细胞和干细胞样白血病细胞的生长。关键的转化包括建立分子的聚酮化合物部分的非对映选择性有机催化交叉羟醛反应,高度受阻的酯片段偶联反应,高效的Helquist型Horner-Wadsworth-Emmons(HWE)大环化以及新的DSC介导的消除反应来构建rakicidin A的敏感APD部分。我们进一步报告了制备具有明显增强的缺氧选择性活性的简化结构类似物(WY1)。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸